Evaluation of CD4+, CD39+, FOXP3+Tregulatory cells in Iraqi Alopecia areata patients by ELISA. (2022). Journal of Pharmaceutical Negative Results, 13, 247-250. https://doi.org/10.47750/pnr.2022.13.S05.32